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In eukaryotic cells, the ribosome-Sec61 translocon
complex (RTC) establishes membrane protein topol-
ogy by cotranslationally partitioning nascent poly-
peptides into the cytosol, ER lumen, and lipid bilayer.
Using photocrosslinking, collisional quenching, cys-
teine accessibility, and protease protection, we show
that a canonical type II signal anchor (SA) acquires its
topology through four tightly coupled and mechanis-
tically distinct steps: (1) head-first insertion into
Sec61a, (2) nascent chain accumulation within the
RTC, (3) inversion from type I to type II topology,
and (4) stable translocation of C-terminal flanking
residues. Progression through each stage is induced
by incremental increases in chain length and involves
abrupt changes in the molecular environment of the
SA. Importantly, type II SA inversion deviates from
a type I SA at an unstable intermediate whose topol-
ogy is controlled by dynamic interactions between
the ribosome and translocon. Thus, the RTC coordi-
nates SA topogenesis within a protected environ-
ment via sequential energetic transitions of the TM
segment.
INTRODUCTION
The biogenesis of most eukaryotic membrane proteins requires
selective delivery of nascent polypeptide domains into the endo-
plasmic reticulum (ER) lumen, the ERmembrane, and the cytosol
(Skach, 2009; von Heijne, 2006). This process is initiated when
a signal sequence emerges from the ribosome, binds signal
recognition particle (SRP), and targets the ribosome and nascent
chain to a membrane protein complex (translocon) comprising
the Sec61abg protein conducting channel (PCC) and its associ-
ated proteins: TRAP, TRAM, oligosaccharyltransferase, signal
peptidase, and others (Johnson and van Waes, 1999; Rapoport,
2007; Shibatani et al., 2005). The X-ray crystal structure of an134 Cell 146, 134–147, July 8, 2011 ª2011 Elsevier Inc.archaebacterial Sec61 homolog identified key structural features
of the PCC, i.e., a signal sequence-binding site, hourglass-
shaped pore, and lateral gate (van den Berg et al., 2004). Inser-
tion of the signal sequence into the PCC is proposed to open the
pore, strengthen ribosome binding to Sec61 (Becker et al., 2009;
Cheng et al., 2005; Jungnickel and Rapoport, 1995; Song et al.,
2000), and establish an aqueous translocation pathway that
extends from the ribosome exit tunnel into the ER lumen (Crow-
ley et al., 1993, 1994). Most secretory proteins and extracyto-
solic domains of transmembrane proteins move through this
pathway coincident with polypeptide elongation (Mothes et al.,
1994; Thrift et al., 1991), whereas membrane protein transloca-
tion is interrupted by synthesis of hydrophobic transmembrane
segments (Liao et al., 1997) that are transferred laterally into
the lipid bilayer (Ismail et al., 2008; Junne et al., 2010; Pitonzo
et al., 2009).
Signal anchor (SA) sequences, like signal sequences, facilitate
SRP-mediated ER targeting to the translocon but ultimately form
helical transmembrane segments (TMs) that span the bilayer in
either a type I (Nexo/Ccyto) or a type II (Ncyto/Cexo) topology
(Higy et al., 2004). The final topology of an SA is the product
of several factors that include (1) flanking charged residues, (2)
hydrophobicity, (3) folding of the N-terminal domain, (4) attach-
ment of N-linked carbohydrates, and (5) composition of
membrane lipids (Denzer et al., 1995; Dowhan and Bogdanov,
2009; Goder et al., 1999; Higy et al., 2004). Among these, flank-
ing charges and hydrophobicity provide the energetics that drive
topogenesis, while folding and glycosylation create a kinetic
block that biases the final topological outcome (Higy et al.,
2004). Because type II SAs translocate their C-terminal flanking
residues into the ER lumen, they must invert end-over-end 180
after exiting the ribosome in order to achieve their proper
topology in the bilayer. Little is known about when and how
such an inversion might take place in the context of the assem-
bled ribosome translocon complex (RTC). One possibility is that
the SA might invert prior to insertion in a tail-first, hairpin-looped
configuration as has been proposed for N-terminal signal
sequences (Rapoport, 2007; Shaw et al., 1988). Alternatively,
in vivo studies show that model SAs can insert head-first into
the translocon (Goder and Spiess, 2003). These results implicate
distinctly different mechanisms as to how the RTC coordinates
proper localization of the nascent chain. Specifically, is SA
topology established within the proteinaceous environment of
the translocon or after the TM segment has integrated into the
lipid bilayer? How is nascent chain delivery to the ER lumen
and cytosol controlled? And, what role does ribosome binding
play in SA topogenesis?
To reconstruct the events of type II SA biogenesis, we exam-
ined a canonical SA derived from the first TM segment of the
aquaporin 4 water channel (AQP4-TM1). Aquaporins (AQPs)
are ubiquitous six-spanning polytopic proteins that facilitate
water and/or glycerol transport across cell membranes (King
et al., 2004). AQP4 utilizes a cotranslational mode of biogenesis
in which individual TM segments encode alternating SA and stop
transfer sequences that interact with Sec61 and direct each
successive peptide loop onto opposite sides of the ER mem-
brane (Foster et al., 2000; Sadlish et al., 2005). Consistent with
this, AQP4-TM1 targets the ribosome nascent chain complex
(RNC) to the ER, inserts into Sec61a, and integrates into the
membrane in a type II topology independent of downstream
TMs. We now show that this topology is established via four
mechanistically distinct steps that begin with head-first insertion
of the TM into a sequestered environment within the RTC. Each
step is triggered by incremental changes in nascent chain length
and coincides with major changes in the molecular environment
of the SA. Importantly, the key transition from a type I to a type II
topology involves a metastable intermediate whose premature
access to the cytosol is prevented by reversible electrostatic
interactions at the ribosome-translocon junction. Type I and
type II SA topogenesis diverges at this late stage of TM inversion
to give rise to different topological outcomes.
RESULTS
Experimental Strategy
SA topogenesis was characterized using assembled integration
intermediates that contained AQP4-TM1 fused to a well-charac-
terized passive C terminus reporter domain (Foster et al., 2000;
Rothman et al., 1988) (Figure 1A). Transcripts were truncated
at sequential sites in the coding sequence and translated
in vitro to generate uniform cohorts of nascent chains that remain
attached to membrane-bound ribosomes via an intact peptidyl-
tRNA bond. Each truncated intermediate therefore provides a
static snapshot of nascent chain architecture within a fully
assembled RTC at a defined stage of synthesis. By analyzing
serially truncated intermediates, it is possible to reconstruct
progressive changes in the molecular environment, transmem-
brane orientation, and cytosolic/lumenal accessibility of TM1
and its flanking residues. The combined use of site-specific pho-
tocrosslinking, fluorescence collisional quenching, cysteine
accessibility, and protease digestion assess multiple features
of the nascent chain and provide a detailed consensus of the
sequential steps by which the RTC facilitates SA topogenesis.
Type II SA Targeting to the ER and Insertion into the RTC
To determine when the RNC first targets to the ER, translation
was carried out in the presence of ER microsomes, and
membrane-bound nascent chains were isolated and quantified(Figures 1A and 1B). Evaluation of peptidyl-tRNA bands, which
reflect intact RNCs, revealed that AQP4-TM1 initiates ER target-
ing at a nascent chain length of 66–71 aa when its C-terminal
boundary has extended approximately 35 residues from ribo-
some peptidyltransferase center (PTC) (Figures 1A and 1B).
Thus, the threshold for targeting occurs just as TM1 emerges
from the ribosome exit tunnel. In addition, RNC attachment to
the ER was partially salt sensitive at truncations 66–71 aa but
became salt resistant for nascent chains 77 aa and longer
(Figure 1B).
We next characterized the molecular environment of TM1
within the RTC by inserting a photocrosslinking probe 3ANB-
Lys near the center of TM1 at an engineered amber (UAG) codon
(Leu28TAG) using a modified suppressor aminoacyl-tRNA
(3ANB-Lys-tRNAamb). Ribosomes that read through the stop
codon incorporate 3ANB-Lys and continue translating to the
end of the truncated transcript, thereby positioning the probe
at a specific location within the RTC. Upon UV irradiation, the
ANB moiety generates a reactive, short-lived nitrene that
promiscuously crosslinks adjacent proteins within reach of the
12 A˚ spacer arm (McCormick et al., 2003; Sadlish et al., 2005).
The efficiency of photoadduct formation therefore approximates
the relative proximity of the probe to neighboring proteins. Quan-
titative immunoprecipitation of photoadducts (described in
Sadlish et al., 2005 and Figures S1A and S1B available online)
revealed three distinct phases of TM1 photocrosslinking to
Sec61a. First, relatively weak photoadducts were detected
coincident with RNC binding to the ER membrane (truncations
66–77, Figures 1C and 1D). Second, photoadducts increased
in intensity nearly 10-fold as the nascent chain was extended
to 98 residues in length. Third, photocrosslinking efficiency
abruptly decreased at truncation 103 and then persisted at an
intermediate level. TM1 therefore resides at a site proximal
enough to crosslink Sec61a at the earliest stage of membrane
targeting and gradually engages the translocon in a more favor-
able conformation before experiencing an abrupt change in
environment as the nascent chain is lengthened just 5 residues,
from 98 aa to 103 aa.
Residue 44, which is 7 aa C-terminal to TM1, also crosslinked
Sec61a (even more efficiently than residue 28) at the earliest
stage of ER targeting (truncation 71, Figure 1E and Figure S1C).
Because the 3ANB-Lys probe is only 27 residues from the PTC at
this stage of synthesis, it likely resides near the end of the ribo-
some exit tunnel where it contacts cytosolic loops of Sec61a
(Becker et al., 2009). In contrast, residue 65 initially crosslinked
Sec61a at truncation 98. The latter photoadducts increased in
intensity as the nascent chain was extended to 110 and 133 aa
while corresponding crosslinks to residues 28 and 44 decreased
(Figure 1E and Figure S1C). Interestingly, residue 2 did not cross-
link Sec61a, but did crosslink TRAM, weakly at truncation 88 and
more strongly at truncations 110 and 133, consistent with
previous reports for N-terminal residues of cleaved signal
sequences (Figure 1F and High et al., 1993). These results iden-
tify multiple translocon components proximal to different regions
of the nascent chain and demonstrate that TM1 and its flanking
residues undergo dynamic transitions within the molecular envi-
ronment of the RTC that are tightly coordinated with nascent
chain elongation.Cell 146, 134–147, July 8, 2011 ª2011 Elsevier Inc. 135
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Figure 1. Nascent Chain Targeting to Sec61a
(A) Autoradiogram of truncated in vitro-translated AQP4-TM1.P showing total products (T), supernatant (S), and membrane pellet (P) fractions analyzed by
SDS-PAGE. Peptidyl-tRNA bands (asterisk) and prematurely released nascent chains lacking tRNA (double asterisk) are indicated.
(B) Fraction of nascent chains (as in A) that remained ER associated ± NaCl treatment as indicated.
(C) Translation products containing a photoactive crosslinker (3ANB-Lys) at residue 28 (and WT constructs lacking UAG codon) were UV irradiated and pelleted.
Translation products were quantified by phosphorimaging (see also Figure S1). Equal amounts were immunoprecipitated with Sec61a antisera and subjected
to SDS-PAGE.
(D) Quantification of photocrosslinks (as in C) after correcting for WT signal.
(E and F) Autoradiogram showing photoadducts to residues 2, 28, 44, and 65 immunoprecipitated with Sec61a (E) or TRAM (F). Graphs show mean (nR 3 ±
SEM).TM1 Inserts into the Translocon in a Head-First,
or Type I, Topology
A critical aspect of membrane protein topogenesis is the mech-
anism by which the RTC selectively delivers polypeptide into
the cytosol and ER lumen. This process can be monitored in
functionally engaged RTCs by incorporating a fluorescent dye
into the nascent chain and measuring the extent of fluorescence
quenching by a membrane-impermeable quenching agent
(Johnson, 2005). The ratio of fluorescence intensity in the
absence and presence of quencher therefore provides a direct
measure of the dye’s accessibility to the compartment contain-136 Cell 146, 134–147, July 8, 2011 ª2011 Elsevier Inc.ing the quenching agent. In this system, surface exposed
cytosolic residues exhibit a relatively high quenching constant
(Ksv4M1, Crowley et al., 1993) that is reduced following trans-
location into the ER lumen and restored by membrane permea-
bilization (Figure S2).
Using this approach, we determined the transmembrane
orientation of TM1 at the earliest stage of ER targeting (truncation
71) by comparing the Stern Volmer quenching constant (Ksv) in
intact and melittin-permeabilized RTCs (Figure 2). A fluores-
cently labeled amino acid, 3NBD-Lys was incorporated at amber
codons located at residue 2 or residue 44 using a synthetic
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Figure 2. TM1 Inserts Head-First into the Translocon
(A) Schematic diagram of RNC and RTC showing relative location of residues
2 and 44.
(B and C) Stern Volmer plots obtained for RNCs and RTCs truncated at codon
71 and containing 3NBD-Lys at residue 2 (B) or 44 (C) (see also Figure S2). Ksv
was determined before and after microsome permeabilization with melittin.
Results show mean (nR 3 ± SEM).suppressor tRNA (3NBD-Lys-tRNAamb). In the absence of ER
microsomes, probes located both N- and C-terminal to TM1
yielded Ksv values typical for surface exposed residues, 4.2 ±
0.3 and 4.2 ± 0.3, respectively (Figures 2B and 2C). In contrast,
both probes were shielded from cytosolic iodide ions (I)
following ER targeting (Ksv = 2.1 ± 0.1 and 1.8 ± 0.4, respec-
tively). Surprisingly, membrane permeabilization restored
quenching of residue 2 (Ksv = 3.8 ± 0.4), but not residue 44
(Ksv = 2.2 ± 0.8). Because the extent of V2NBD-Lys quenching
following permeabilization was indistinguishable from free
RNCs, the N terminus of TM1 becomes accessible to the ER
lumen upon membrane targeting. In contrast, residue 44, which
is located near the cytosolic vestibule of Sec61a, remained
shielded from both lumenal and cytosolic I (Figure 2C). Thesefindings, together with crosslinking results shown in Figure 1,
suggest that AQP4-TM1 initially inserts into the translocon at a
site proximal to Sec61a in a ‘‘head-first’’ (type I) topology.
Inversion of TM1 from a Type I to a Type II Topology
To determine the stage of synthesis at which TM1 begins to
attain a type II topology, we measured quenching constants
for V2NBD-Lys and L44NBD-Lys as the nascent chain was
extended from 71 to 133 aa. V2NBD-Lys remained accessible
to lumenal I- during synthesis of approximately 27 additional
residues (truncations 71 aa to 98 aa) as demonstrated by an
initial low Ksv and a 2 fold increase after membrane permeabi-
lization (Figure 3A). In contrast, L44NBD-Lys continued to exhibit
low I accessibility both before and after permeabilization (Fig-
ure 3B). At truncation 98, residue 44 is 54 aa from the PTC and
has likely emerged from the ribosome exit tunnel. Yet the low
level of quenching indicates that this region of nascent chain
has not yet passed through the translocon pore. Because
residue 44 crosslinks Sec61a at this truncation, (Figure 1E), we
conclude that TM1 C-terminal flanking residues accumulate
near the ribosome exit site and cytosolic vestibule of the translo-
con in an environment that is relatively inaccessible fromboth the
cytosol and ER lumen (Figure 3C).
As the nascent chain was extended from 98 aa to 110 aa,
residue 44 abruptly became accessible to lumenal I as demon-
strated by a 2-fold increase in Ksv uponmembrane permeabiliza-
tion (Figure 3B). V2NBD-Lys also exhibited a reduction in ΔKsv
following membrane permeabilization (Figure 3A), although the
extent of V2NBD-Lys quenching was less than expected for
a fully exposed residue. This latter finding could occur if the short
(13 aa) N terminus remained partially shielded beneath the base
of the ribosome (see Figures 5H and 5I), if it remained associated
with one or more ER proteins, i.e., TRAM (Figure 1F), or if N
terminus inversion were slightly delayed relative to C terminus
translocation. When fluorescence quenching results are evalu-
ated in the context of photocrosslinking data (Figures 1C–1E),
they indicate that TM1 inversion is initiated as the nascent chain
increases from 98 to 110 aa and is associated with a major tran-
sition of TM1 within the proteinaceous environment of the RTC.
Nascent Chain Accumulates within the RTC Prior
to TM1 Inversion
To better evaluate nascent chain accessibility, we examined the
ability of engineered cysteine residues to undergo covalent
modification by an aqueous, membrane-impermeant polyeth-
ylene glycol-maleimide derivative, PEG-Mal5000 (Figure S3 and
Lu and Deutsch, 2005). In free RNCs, pegylation of Cys44
(L44C) increased and then plateaued as the nascent chain was
extended from 71 to 77 aa, indicating that the SH group exits
the ribosome as the polypeptide tether from the PTC is extended
from 27 to 33 residues in length (Figures 4A and 4C). After
membrane targeting, however, Cys44 was completely shielded
from PEG-Mal, but became accessible upon SDS denaturation
(Figures 4B and 4C). Microsome permeabilization with digitonin
and to a lesser extent melittin, also resulted in Cys44 pegylation,
but only at nascent chain lengths >110aa (Figure 4D). Thus, these
latter agents do not disrupt ribosome binding but allow PEG-Mal
to access residues that have entered the ER lumen. In contrast,Cell 146, 134–147, July 8, 2011 ª2011 Elsevier Inc. 137
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Figure 3. Initiation of TM1 Inversion from a Type I to a Type II Topology
Ksv valueswere determined as in Figure 2 for probes located at residue 2 (A) or 44 (B) in RTCs before (gray bars) and after (black bars) membrane permeabilization.
Data show average Ksv values obtained for indicated chain lengths (n R 3 ± SEM). (C) Schematic of RTC showing probable location of fluorescent
probes (circles).TX-100 exposed TM1 C-terminal residues to PEG-Mal even at
chain lengths of 77–98 aa, indicating that the ribosome-translo-
con junction issensitive tocertainnonionicdetergents (Figure4F).
Additional C-terminal residues, Cys34, Cys49, and Cys65, were
also shielded from cytosolic and lumenal PEG-Mal in both intact
and digitonin-solubilized RTCsat chain lengths%111 aa (Figures
4E and 5B–5E), whereas the N-terminal residue Cys9 was inac-
cessible in intact microsomes but pegylated after digitonin per-
meabilization (Figure 4G and Figure S4). These results confirm
that N-terminal residues are exposed to the ER lumen upon
membrane targeting and that ribosome binding protects a
substantial region of the elongating polypeptide from the cytosol
as it accumulates within the RTC prior to TM1 inversion.
Role of the Ribosome Junction in SA Inversion
To determine whether the ribosome plays a direct role in SA
inversion, we first tested whether residues that were shielded
by the intact RTC but not yet translocated into the ER lumen,
might become exposed to cytosol if the ribosome junction
were perturbed by addition of 0.5 M NaCl (Figure 5A). Prior to
salt treatment, low levels of pegylation were observed for Cys
residues both within and C-terminal to TM1 (residue 34 and resi-
dues 44, 49, and 65, respectively, Figures 5B–5E). Following
NaCl addition, no detectable increase in pegylation occurred
for residue 34, indicating that the hydrophobic core of TM1
resides in a salt-insensitive environment. However, all three
C-terminal residues were pegylated in the presence of NaCl
with consistent bimodal peaks at truncations 98 and 111. Ribo-138 Cell 146, 134–147, July 8, 2011 ª2011 Elsevier Inc.some binding therefore establishes electrostatic interactions
that shield the nascent chain from cytosol prior to TM inversion.
As the nascent chain was extended to 133 aa, salt no longer
affected pegylation, satisfying the prediction that high ionic
strength should not increase accessibility of cysteine residues
after they have translocated into the ER lumen. Unexpectedly,
pegylation was partially reduced by salt at truncation 103, the
same stage of synthesis at which TM1 photocrosslinking to
Sec61a abruptly decreased (Figures 1C and 1D). In addition,
when microsomes were preincubated in 0.5 M NaCl and resus-
pended in low-salt buffer, pegylation was reduced to control
levels, whereas addition of NaCl to repelleted microsomes
increased pegylation irrespective of prior salt treatment (Figures
5F and 5G). Thus, nascent chain shielding by the ribosome trans-
locon junction is reversible, occurs spontaneously, and does not
require salt-dissociable factors.
We also noted that the increase in cytosolic exposure of Cys44
at truncation 110 in the presence of high salt contrasts with the
increase in lumenal I quenching of L44NBD-Lys following
melittin permeabilization. At this chain length, TM1 C-terminal
residues can therefore be accessed from either the ER lumen
or the cytosol depending upon whether the ribosome-translocon
junction remains intact. This suggested that junctional interac-
tions might prevent inappropriate access of the nascent chain
to the cytosol, possibly by preventing backsliding during the
critical transition of TM1 from a type I to a type II topology.
To test this hypothesis, microsomes were digested with
RNase to remove ribosomes from arrested RTCs (Figure S5A).
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Figure 4. Nascent Chain Shielding by the RTC
(A and B) Transcripts containing L44C were translated in the absence (A) or presence (B) of ER microsomes. Pelleted RNCs and RTCs were incubated with
PEG-Mal ± SDS as indicated. Pegylated (P) and unpegylated (UP) peptidyl-tRNA bands are indicated (see also Figure S3).
(C) Fraction of pegylated nascent chains (as in A and B) were quantified and plotted against chain length.
(D and E) Fraction of pegylated RTCs containing Cys44 (D) or Cys34, Cys49, Cys65 (E) following permeabilization with digitonin or melittin.
(F) Pegylation of Cys34, Cys44, and Cys49 in RTCs solubilized with TX-100.
(G) Pegylation efficiency of residue Cys9 in intact and digitonin solubilized RTCs (see also Figure S4). Graphs show mean (n = 3 ± SEM).Following digestion, the N terminus of nascent chains 71–110 aa
in length remained in the ER lumen (Figures 5H and 5I), while
C-terminal residues (Cys49) remained accessible to cytosolicPEG-Mal (Figures S5B and S5C). Thus, nascent chains that
have not yet inverted, retain their initial type I topology following
ribosome removal. In contrast, RNase digestion of longerCell 146, 134–147, July 8, 2011 ª2011 Elsevier Inc. 139
PEG-MAL
NaCl 0.5M
- + - + - + + - + +
- - + + - - + - - +
Pre Incubation - - - - + + + + +
0M 0.5M
+
98aa
110aa
30
30
Truncation
P
UP
P
UP
F
1 2 3 4 5 6 7 8 9 10 0
0.1
0.2
0.3
0.4
0M 0.5M 0M 0.5M
 [NaCl] During Pegylation
0
0.1
0.2
0.3
0.4
0.5
0M 0.5M 0M 0.5M
[NaCl] During Pegylation
98aa 110aa
G
Fr
ac
tio
n 
P
eg
yl
at
ed
B
44Cys
0
0.2
0.4
0.6
66 86 106 126
Chain length (aa)
49Cys
0
0.2
0.4
0.6
66 86 106 126
Chain length (aa)
+ NaCl
– NaCl
65Cys
0
0.2
0.4
0.6
66 86 106 126
Chain length (aa)
+ NaCl
– NaCl
44
49
65
A
+ NaCl
– NaCl
+ NaCl
C D
Fr
ac
tio
n 
P
eg
yl
at
ed 34Cys
+ NaCl
– NaCl
0
0.2
0.4
0.6
66 86 106 126
E
34
H
PEG-MAL
Digitonin
- + +
- - +
71 88 98 103 110 153133
- + +
- - +
- + +
- - +
- + +
- - +
- + +
- - +
- + +
- - +
- + +
- - +
P
UP
15 kDa
30 kDa
N
RNase
T9C
N
+ NaCl
– NaCl
9Cys (+ RNase)
Fr
ac
tio
n 
P
eg
yl
at
ed
Chain length (aa)
I
9Cys + RNase
RNase 0
0.1
0.2
0.3
71 88 98 103 110 133 153 163
RNase
RNase + Digitonin
Figure 5. Ribosome Shielding Is Salt Sensitive, Reversible, and Required for TM1 Inversion
(A) Schematic RTC showing potential effect of NaCl before and after TM1 inversion.
(B–E) RTCs containing a Cys residue at position 34 (B), 44 (C), 49 (D), or 65 (E) were pegylated ± addition of 0.5MNaCl. Fraction of pegylated peptidyl tRNA bands
was determined as in Figure 4.
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Figure 6. Proteolytic Susceptibility of the Ribosome-Translocon Junction
(A) Autoradiogram showing truncated peptidyl-tRNA bands ± PK digestion (downward arrows show protected bands).
(B) PK digestion of nascent chains labeled with [14C]Lys at indicated UAG stop codons. Five to 7 kDa N-terminal fragments (bracket) contain residues 2 and
44 while C-terminal peptidyl-tRNA fragments (horizontal arrow) contain residue 65. For truncation 110, intensity of latter bands reflects partial removal by PK.
Double asterisks indicate released nascent chains.
(C) RTCswere subject to PK digestion as in (A), but in the presence of 0.5MNaCl and/or digitonin as indicated. PK protected Peptidyl tRNA bands in the presence
of NaCl (downward arrowhead.truncations (R133 aa) resulted in a stable type II topology
with Cys9 becoming progressively accessible to cytosolic
PEG-Mal (Figures 5H and 5I) and Cys49 accessible to lumenal
Peg-Mal (Figure S5C). These results verify that TM1 inversion
involves reciprocal movement of N- and C-terminal flanking resi-
dues and indicate that type II topology requires the ribosome to
be present at the stage of synthesis when TM inversion is
initiated.(F) RTCs containing L44C (truncated at residue 98 or 110 aa) were incubated wi
(lanes 1–4) or repelleted and pegylated in the presence (lanes 7 and 10) and abs
(G) Quantification of experiments (as in F) showing no preincubation (white bars), p
Mean values (n = 3, ±SEM).
(H and I) Pegylation efficiency of Cys9 in RTCs digested with RNase and treatedTopological Inversion Involves Dynamic Protein
Interactions at the Ribosome-Translocon Junction
To determinewhether protein components contribute to nascent
chain shielding, we tested whether the ribosome translocon
junction was susceptible to protease digestion. Consistent with
previous studies (Jungnickel and Rapoport, 1995; Matlack and
Walter, 1995), short nascent chains were protected from pro-
teinase K (PK) by the RTC (Figure 6A, lanes 1–8). However, asth (lanes 3 and 4) or without (lanes 1 and 2) 0.5 M NaCl and pegylated directly
ence (lanes 6 and 9) of 0.5 M NaCl.
reincubation without NaCl (gray bars), or preincubation with NaCl (black bars).
as indicated (see also Figures S4 and S5). Graphs show mean (n = 3, ± SEM).
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the length of polypeptide tether from TM to the PTC increased
(truncations 98, 103, 110), PK generated peptidyl-tRNA frag-
ments with increased mobility (Figure 6A, lanes 9–14). Labeling
nascent chains with a single [14C]Lys residue further demon-
strated that PK cleavage occurred between residues 44 and
65, a region of polypeptide that is cytosolically inaccessible in
intact RTCs when probed by both quenching and pegylation
(Figure 6B). These results indicate that polypeptide sequestered
in the RTC can become exposed when protein components
responsible for shielding are digested. As expected, nascent
chains re-acquired partial protease protection at truncations
125 and 133 in intact but not solubilized microsomes. Thus,
even though the nascent chain is longer, the effective tether
length to the PTC becomes too short to allow PK access beneath
the ribosome after translocation of C-terminal residues through
the translocon pore (Figure 6A, lanes 15–20).
Nascent chains 77 aa in length also remained PK protected
following addition of 0.5 M NaCl, whereas truncation 93 became
cytosolically accessible (Figure 6C). Thus, the peptide tether is
marginally long enough for PK to access the nascent chain at
this latter stage but only if the ribosome junction is also perturbed
by high salt. Paradoxically, NaCl had the opposite effect at
truncation 103, converting the junction to a more protease resis-
tant state. This behavior parallels the decrease in pegylation
observed at the same chain length (Figures 4F and 5B–5E) and
indicates that the junction transiently becomes less susceptible
to perturbation at this stage of synthesis. As expected, salt
had no effect on protease protected nascent chains that
achieved a type II topology (truncation 133), although some
chains that had not yet fully inverted remained protease acces-
sible. Thus, TM inversion and movement within the translocon
coincides with interconversion of the junction between
protease-, salt-, and detergent-sensitive and resistant states.
Type I and Type II SAs Diverge at a Late Stage
of Topogenesis
Our findings predict that in order to generate different topolog-
ical outcomes, the events that direct type II and type I SA
topology should diverge at some point during synthesis. To
determine when this occurs, TM1 was converted to a type I
SA by reversing two N-terminal charges (K5D, K14D) and
replacing Glu41 with three Arg residues (E41R3, Figure 7A).
Type I topology was confirmed by protease protection (80%
of the reporter domain was cytosolic), and N-linked glycosyla-
tion (albeit inefficient) of a parallel construct containing an
N-linked consensus site (NSS) in a short N-terminal extension
(Figures 7A and 7B and Figure S6B). Interestingly, glycosylation
occurred only in the type I construct and only after the nascent
chain reached a length of 135 aa (Figures S6C and S6D). This
corresponds to the stage of synthesis when TM1 has disen-
gaged from its optimal crosslinking site in Sec61 and N-terminal
residues of the type II SA have begun to reorient toward the
cytosol. Thus, head-first insertion of the type II SA does not
correctly position the consensus site for recognition by OST
even though N-terminal residues transiently sample the lumenal
environment (Figure S6).
Upon membrane targeting, C-terminal residues flanking the
type I SA (Cys46, new numbering scheme), like those of the142 Cell 146, 134–147, July 8, 2011 ª2011 Elsevier Inc.type II SA, became shielded from cytosolic PEG-Mal by a salt-
sensitive ribosome junction and remained shielded as the
nascent chain was extended to at least 112 aa (Figures 7C and
7D). For longer truncations (R135 aa), C-terminal residues grad-
ually became cytosolically accessible. This result differs from the
type II SA in which C-terminal residues remained shielded from
the cytosol, became salt resistant, and were pegylated only after
membrane permeabilization. Thus the type I nascent chain
emerges from beneath the ribosome at roughly the same stage
of synthesis when corresponding residues in the type II SA
move into the ER lumen. Consistent with this, the RTC protected
short nascent chains (truncations 73–90) containing a type I SA
from protease, whereas intermediate lengths (truncations
95–112) were cleaved by PK (Figure 7E). At longer truncations
(127 and 135 aa), however, less than 20% of typeI chains re-
acquired protease protection, compare to nearly 50% of type II
chains (Figure 7E). Early events of membrane targeting, ribo-
some binding, and nascent chain shielding are therefore similar
for type I and type II SAs. However, their respective mechanisms
of topogenesis diverge at a relatively late stage when C-terminal
flanking residues are either committed for ER translocation or al-
lowed access to the cytosolic compartment.
DISCUSSION
This study provides new insight into membrane protein biogen-
esis by characterizing the detailed mechanism of type II SA
insertion and orientation within the mammalian RTC. When
taken together, site-specific photocrosslinking, fluorescence
collisional quenching, cysteine accessibility, and protease
digestion of programmed integration intermediates provide
a remarkably consistent view of the coordinated changes that
control nascent chain environment within the RTC, orientation
of the SA with respect to the ER membrane, and accessibility
of flanking residues to cytosol and ER lumen. Several key find-
ings can be drawn from the present study. First, SA topogenesis
involves at least four mechanistically distinct steps that are
tightly coupled to incremental changes in nascent chain length.
These include (1) ER targeting and head-first insertion into the
translocon, (2) accumulation of elongating the nascent chain in
a protected proteinaceous environment within the RTC, (3) topo-
logical inversion from a type I to a type II topology, and (4) stable
translocation of C-terminal flanking residues into the ER lumen.
Second, each stage of topogenesis involves discrete, stepwise
molecular rearrangements of the SA within the RTC. Third,
stable topology is established via a novel intermediate in which
nascent chain accessibility is dependent upon reversible and
dynamic conformational changes at the ribosome translocon
junction.
The first stage of topogenesis occurs as the SA emerges from
the ribosome, targets the RNC to the ER membrane, and inserts
into Sec61awith its N-terminal residues exposed to the ER lumen.
Thus, initial insertion occurs in a head-first (type I) topology as
proposed by the Spiess group (Goder and Spiess, 2003), rather
than in the widely depicted hairpin model (Rapoport, 2007; Shaw
et al., 1988). Coincident with these events, protein interactions
between the ribosome and translocon shield C-terminal flanking
residues from both lumenal and cytosolic compartments. Type II
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Figure 7. Type I Signal Anchor Insertion
(A) Schematic showing engineered N-linked glycosylation site (N-glc) and mutations used to reverse TM1 topology.
(B) PK protection of (membrane targeted) type I and type II AQP4-TM1.P ±N-glc. Asterisk indicates full-length protein (see also Figure S6). Double asterisk shows
a minor population cleaved at a cryptic signal peptidase site (described previously [Foster et al., 2000]). Cleavage is observed only for truncations >133 aa
(not shown). Downward arrow indicates glycosylated band (see also Figure S6). Graph shows percent of chains with translocated C terminus (type II topology,
mean of two experiments).
(C and D) Mean pegylation efficiency of Cys46 for type I construct (n = 3, ± SEM). Truncations are at same sites as type II constructs, but numbering reflects
addition of Arg residues (E41R3).
(E) Protease protection of type I RTCs at indicated truncations. Graph shows mean C terminus translocation efficiency for type I and type II nascent chains
(n = 3, ± SEM [type II] or average of two experiments [type I]).SAs, likeN-terminal signal sequences (Crowley et al., 1994), there-
fore establish a ‘‘tight’’ ribosome-translocon junction that prevents
the nascent chain from prematurely accessing the cytosol.During the second stage of topogenesis, the SA remains in
a type I topology but moves into a different molecular environ-
ment as evidenced by a 10-fold increase in TM1-Sec61aCell 146, 134–147, July 8, 2011 ª2011 Elsevier Inc. 143
photocrosslinking. C-terminal flanking residues also crosslink
Sec61a but remain inaccessible to both the cytosol and ER
lumen. Thus a substantial region of polypeptide (30 aa) accu-
mulates near the ribosome exit tunnel and cytosolic vestibule
of Sec61. At this stage of synthesis, perturbation of ribosome
binding with high salt and/or PK exposes sequestered polypep-
tide to cytosolic agents. This could occur by disrupting electro-
static interactions between Sec61a (e.g., L6, L8, and C terminus)
and ribosomal RNA (H50, H53, H24) and/or ribosomal proteins
(rpl17, rpL25, rpl26) (Becker et al., 2009; Cheng et al., 2005;
Pool, 2009). Alternatively, because the ribosome protects
Sec61 from proteolytic attack (Kalies et al., 1994), salt and
protease effects could be mediated by interactions with addi-
tional translocon-associated proteins such as oligosaccharyl-
transferase, TRAP, TRAM, or others (Hegde and Lingappa,
1996; Pool, 2009; Shibatani et al., 2005).
The third stage of topogenesis involves a metastable interme-
diate that heralds the onset of TM1 inversion. At a nascent chain
length of 98 aa, TM1 is in a type I topology and tethered to the
PTC by a span of 62 residues, a length nominally sufficient to
traverse the ribosome exit tunnel and translocon (Mingarro
et al., 2000). Synthesis of only 5 additional residues (truncation
103) displaces the SA from its site adjacent to Sec61a and tran-
siently converts the ribosome translocon junction to a salt- and
TX-100-resistant state. This is followed, at truncation 110, by
an abrupt increase in the lumenal accessibility of C-terminal
residues, reflecting either initial SA inversion or a structural
change in the translocon that allows I to access the nascent
chain from the ER lumen (Crowley et al., 1993, 1994). Remark-
ably, these C-terminal flanking residues become cytosolically
accessible when ribosome binding is perturbed by either high
salt or proteolytic digestion. The abrupt transition in lumenal
accessibility is therefore coupled to physical displacement of
the SA within the RTC and simultaneous alteration of junctional
interactions that prevent premature access to the cytosol.
The final stage of topogenesis is characterized by TM1 inversion
and acquisition of a stable type II topology. At chain lengths of
125–133 aa, fluorescence quenching, pegylation and protease
protection invariably support the translocation of TM1 C-terminal
residues into the ER lumen. The short N terminus, which remains
shielded by the ribosome, also becomes cytosolically accessible
upon ribosome removal, although full exposuremay be somewhat
delayed. As the tether length between TM1 and the PTC is
increased, nascent chain topology becomes independent of ribo-
some binding and is likely stabilized by other interactions with
Sec61, TRAM, lipids, and/or possibly lumenal components.
Notably, the type II SA diverges from the type I SA at this stage of
synthesis, whenC-terminal flanking residues are either committed
to translocate into the ER lumen or move into the cytosol.
One question arising from these findings is how the translocon
mediates this remarkable sequence of events. Crystal structures
of SecY together with crosslinking studies have suggested that
signal sequences insert into a lateral cleft between TM 2b and
TM7 of Sec61 (Plath et al., 2004; van den Berg et al., 2004),
thereby opening the translocon pore and initiating translocation
(Cannon et al., 2005). In contrast to the hairpin-loopmodel where
C-terminal residues enter the pore coincident with SA insertion
(Rapoport, 2007; Shaw et al., 1988), the present study implicates144 Cell 146, 134–147, July 8, 2011 ª2011 Elsevier Inc.a mechanism in which N-terminal flanking residues are initially
translocated into the ER, and opening of the lumenal pore and
C terminus translocation occur at a later stage of translation.
Systematic changes in Sec61a photocrosslinking therefore
indicate that the proteinaceous interior of the translocon either
contains multiple sites that can accommodate the SA or a highly
dynamic site whose character changes significantly during
the inversion process. This concept is supported by the ability
of OST tomodify lumenal N-linked glycosylation consensus sites
only during the last stage of topogenesis. One possibility is that
the increase in early Sec61a crosslinking (truncations 71–98)
coincides with SA movement into the lateral gate, whereas the
subsequent decrease (truncations 98–104) reflects partial
release from this site as inversion is initiated.
An intriguing and still enigmatic issue is how N-terminal resi-
dues return to the cytosol as C terminus translocation is initiated.
While multiple peptide strands might be accommodated within
alternate translocation pathways (Kida et al., 2007), recent
studies have implicated a monomeric protein conducting
channel as the functional unit (Becker et al., 2009). A single
Sec61abg heterotrimer, however, is clearly too small to accom-
modate rotation of a rigid helix. Therefore, either Sec61 together
with its accessory proteins must provide sufficient space for
helix inversion and transport of N-and C-terminal residues,
TM1 must exhibit a significant degree of flexibility/unfolding, or
inversion must take place at least partially outside but adjacent
to Sec61a (Brambillasca et al., 2006; Kida et al., 2010). Structural
studies of fully assembled translocons containing RNCs at
different stages of topogenesis will likely be needed to resolve
these scenarios.
What then provides the driving force for SA inversion? The
final orientation of an SA is determined in part by the balance
between hydrophobic and electrostatic interactions with
Sec61a (Higy et al., 2004), TRAM (Mothes et al., 1994), and/or
membrane lipids (Dowhan and Bogdanov, 2009; Hessa et al.,
2007). TM1 N and C termini contain a net charge of +3 and
1, respectively, thereby favoring a type II topology according
to the ‘‘positive inside rule’’ (von Heijne, 2006). To explain our
findings, we propose a simple model in which the translocon
mediates SA topogenesis by catalyzing two sequential energetic
transitions: (1) insertion, which is driven primarily by the hydro-
phobic effect and (2) inversion, which is driven by electrostatic
interactions. Because TM1 is highly hydrophobic, initial insertion
into the translocon is likely stabilized by decreased exposure to
aqueous solvent (Hessa et al., 2007; Junne et al., 2010). At the
same time, insertion may induce an electrostatic strain from
the oriented dipole moment in ribosome-bound Sec61 (Higy
et al., 2004). Such a model would predict the existence of tran-
sient intermediates at early stages of synthesis where topology
is dependent on the net outcome of these forces. Indeed,
reversing the net flanking charge (N, 1; C, +3) converted
TM1 to a type I SA but had no detectable effect on ribosome
shielding at short nascent chain lengths. Thus, initial targeting
and insertion events are similar irrespective of the final topolog-
ical outcome. As the nascent chain reaches a critical length
(127–133 in this construct), ribosome binding is required for
inversion of the type II SA, whereas shielding becomes dimin-
ished for the type I SA and C-terminal residues are directed
into the cytosol. Importantly, head-first insertion is not neces-
sarily a prerequisite step for all SAs. Hairpin insertion could
result if the energetic cost of maintaining the SA (or signal
sequence) in the aqueous space beneath the ribosome were
less than the electrostatic strain (Shaw et al., 1988; von Heijne,
2006) or if the SA were preceded by a large globular domain
which could slow or block insertion kinetics. The mode of inser-
tion would also be dependent on additional parameters
including the rate of translation, kinetics of SRP release after
membrane targeting, and the rate of RNC transfer to Sec61
(Song et al., 2000). If, for example, translation (after SRP release
of the SA) proceeded faster than insertion, then sufficient
nascent chain could potentially accumulate beneath the ribo-
some to allow for hairpin insertion.
Our model also predicts that for inversion to take place, TM1
should disengage from its initial (hydrophobic) binding site in
Sec61. The resulting increase in rotational freedom could then be
coupled either directly or indirectly through conformational
changes at the ribosome junction that ensure C terminus translo-
cation, and thereby relieve electrostatic strain as the tether is
lengthened. Both of these requirements, TM1 displacement and
altered junctional interactions, were observed at truncation 103.
While the events that trigger these conformational changes remain
uncertain, they are likelymediated by the location, orientation, and
physical properties of the SA as has been proposed for N-terminal
signal sequences (Rutkowski et al., 2001). It is tempting to specu-
late that dynamic communication between the ribosome and
translocon identified here contribute to the transient cytosolic
exposure of secretory proteins induced by pause transfer
sequences (Hegde and Lingappa, 1996), inefficient translocation
observed for a subset of N-terminal signal sequences (Kim et al.,
2002), and possibly selective effects of certain translocation
inhibitors (Garrison et al., 2005). The observation that topological
transitions are tightly coupled to nascent chain length is also sig-
nificant for polytopicmembraneproteinswheremultiple transloca-
tion events are required to deliver peptide loops into the ER lumen
(Sadlish et al., 2005). A future challenge, therefore, is to determine
how the translocon accommodates the diverse repertoire of
natural SAs and whether yet additional mechanisms of transloca-
tion initiation and reinitiation are possible.
EXPERIMENTAL PROCEDURES
Plasmid Construction
AQP4 TM1 fusion protein (AQP4-TM1.P) contains AQP4 residues Met1 to
Val46, a Thr-Val linker, and the C-terminal 142 residues from bovine prolactin
in a pSP64 (Promega) vector described elsewhere (Foster et al., 2000). Indi-
cated mutations were incorporated into the coding sequence using PCR over-
lap extension. A glycosylation site was inserted N-terminal to TM1 by replacing
Met1 with cDNA encoding MGNSS.
In Vitro Transcription/Translation
AQP4-TM1.P cDNA was amplified by PCR, transcribed in vitro using SP6
RNA polymerase, and translated in rabbit reticulocyte lysate (RRL) in the
presence or absence of canine pancreatic microsomes. Where indicated [14C]
Lys-tRNAamb, N3-(5-azido-2-nitrobenzoyl)[14C]Lys-tRNAamb (3ANB-[14C]Lys-
tRNAamb) or N3-6-(7-nitrobenz-2-oxa-1,3-diazole)-[14C]Lys-tRNAamb (3NBD-
[14C]Lys-tRNAamb) was added to final concentration of 0.8–1.0 mM. tRNAs
were synthesized, modified, and purified as described previously (Sadlish
et al., 2005). For biochemical studies, RNCs and microsomes were isolated bypelleting and resuspended in 50 mM HEPES-KOH (pH 7.5), 100 mM KCl, 5 mM
MgCl2, and 1 mMDTT with (microsomes) or without (RNCs) 0.1 M sucrose.
Photocrosslinking
Nascent chains containing 3ANB-Lys-tRNAamb were exposed to UV irradiation
on ice for 10min and were either analyzed directly by SDS-PAGE (Figure S1) or
immunoprecipitated following SDS denaturation. Radiolabeled bands were
quantified by phosphorimaging as described previously (Sadlish et al., 2005).
Fluorescence Quenching
Parallel translation reactions containing 3NBD- [14C]Lys-tRNAamb or [14C]Lys-
tRNAamb (spectral control) were performed and subjected to gel filtration with
Sephadex CL-6B or CL-2B to isolate free and membrane-bound RNCs,
respectively. Baseline steady-state NBD emission intensity was measured
using a Fluorolog 3-2-2 fluorimeter (Horiba Scientific) prior to and following
addition of KI solution and melittin (for membrane bound RNCs) essentially
as described previously (Crowley et al., 1994). Quenching constants were
determined using the Stern-Volmer equation:
ðF0=FÞ  1= Ksv

I

where F0 is the net initial emission intensity and F is the emission intensity after
addition of [I]. Ksv = kqtwhere kq is the bimolecular quenching constant and t
is the fluorescence lifetime. Because t, and hence the emission intensity, is
environmentally sensitive, the emission intensity per nM concentration of
3NBD- [14C]Lys incorporated (i.e., photons/sec/nM) was determined at the
end of each experiment for each sample using the photon counting and
[14C]Lys scintillation counting data. No major variation in fluorescent yield
was observed for various truncations at a each probe site. Thus the NBD life-
times were similar for each set of intermediates, and I- accessibility can be
assessed by comparing Ksv values.
Mass Tagging with PEG-MAL
Pelleted microsomes and RNCs were incubated on ice with 2 mM
PEG-Mal5000 (Biochimika) and 50 mM DTT. Where indicated, 0.2% (w/v)
SDS, 1% (v/v) Triton X-100, 2% (w/v) digitonin, and 1.6 mM melittin or 0.5 M
NaCl were added prior to PEG-Mal. Where indicated, samples were incubated
with (10 mg/ml) RNase or 1 mM puromycin prior to addition of PEG-Mal. The
reaction was quenched by addition of equal volume of 400mMDTT and added
directly to SDS-loading buffer. Pegylation efficiency was calculated from the
band intensities of pegylated (P) and unpegylated (UP) peptidyl-tRNA bands
using the formula: Fraction Pegylated = P/(UP+P).
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